Trial Profile
The Effect of Coadministration of BMS-955176 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs GSK 3532795 (Primary) ; Ethinylestradiol/norgestimate
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 09 Feb 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Jun 2014 New trial record